Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Purdue

Showing results (41-50 of 334) with videos related to

Pageof 34
Sort By:
Cancer Causes & Control : CCC|September 1, 2005
Hormone replacement therapy, reproductive history, and colorectal adenomas: data from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial (United States)Mark P Purdue, Pamela J Mink, Patricia Hartge, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|March 10, 2011
Risk of kidney cancer and chronic kidney disease in relation to hepatitis C virus infection: a nationwide register-based cohort study in SwedenJonathan N Hofmann, Anna Törner, Wong-Ho Chow, et al.
Plos Computational Biology|July 12, 2023
Improve the model of disease subtype heterogeneity by leveraging external summary dataSheng Fu, Mark P Purdue, Han Zhang, et al.
Cancer Medicine|December 30, 2015
Racial disparities in overall survival among renal cell carcinoma patients with young age and small tumorsKendra Schwartz, Julie J Ruterbusch, Joanne S Colt, et al.
Cancer Causes & Control : CCC|May 10, 2017
Circulating levels of obesity-related markers and risk of renal cell carcinoma in the PLCO cancer screening trialLinda M Liao, Jonathan N Hofmann, Eunyoung Cho, et al.
Cancer Research|June 3, 2011
Prediagnostic serum levels of cytokines and other immune markers and risk of non-hodgkin lymphomaMark P Purdue, Qing Lan, Rachel Bagni, et al.
Epidemiology (Cambridge, Mass.)|April 23, 2015
The authors respondJonathan N Hofmann, Douglas A Corley, Joanne S Colt, et al.
Cytokine|March 7, 2017
Impact of freeze-thaw cycles on circulating inflammation marker measurementsWen-Yi Huang, Troy J Kemp, Ruth M Pfeiffer, et al.
Leukemia & Lymphoma|July 17, 2025
Pre-diagnostic serum concentrations of free light chains and risk of non-Hodgkin lymphoma in a population-based prospective studyWei Hu, Ola Landgren, Bryan A Bassig, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 8, 2010
International trends in the incidence of testicular cancer, 1973-2002Victoria M Chia, Sabah M Quraishi, Susan S Devesa, et al.
Pageof 34

Showing results (41-50 of 334) with videos related to

Sort By:
Pageof 34
Cancer Causes & Control : CCC|September 1, 2005
Hormone replacement therapy, reproductive history, and colorectal adenomas: data from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial (United States)Mark P Purdue, Pamela J Mink, Patricia Hartge, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|March 10, 2011
Risk of kidney cancer and chronic kidney disease in relation to hepatitis C virus infection: a nationwide register-based cohort study in SwedenJonathan N Hofmann, Anna Törner, Wong-Ho Chow, et al.
Plos Computational Biology|July 12, 2023
Improve the model of disease subtype heterogeneity by leveraging external summary dataSheng Fu, Mark P Purdue, Han Zhang, et al.
Cancer Medicine|December 30, 2015
Racial disparities in overall survival among renal cell carcinoma patients with young age and small tumorsKendra Schwartz, Julie J Ruterbusch, Joanne S Colt, et al.
Cancer Causes & Control : CCC|May 10, 2017
Circulating levels of obesity-related markers and risk of renal cell carcinoma in the PLCO cancer screening trialLinda M Liao, Jonathan N Hofmann, Eunyoung Cho, et al.
Cancer Research|June 3, 2011
Prediagnostic serum levels of cytokines and other immune markers and risk of non-hodgkin lymphomaMark P Purdue, Qing Lan, Rachel Bagni, et al.
Epidemiology (Cambridge, Mass.)|April 23, 2015
The authors respondJonathan N Hofmann, Douglas A Corley, Joanne S Colt, et al.
Cytokine|March 7, 2017
Impact of freeze-thaw cycles on circulating inflammation marker measurementsWen-Yi Huang, Troy J Kemp, Ruth M Pfeiffer, et al.
Leukemia & Lymphoma|July 17, 2025
Pre-diagnostic serum concentrations of free light chains and risk of non-Hodgkin lymphoma in a population-based prospective studyWei Hu, Ola Landgren, Bryan A Bassig, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 8, 2010
International trends in the incidence of testicular cancer, 1973-2002Victoria M Chia, Sabah M Quraishi, Susan S Devesa, et al.
Pageof 34